How do I know if tirzepatide will work for me: 7 factors

An analysis of four studies conducted by Eli Lilly, the maker of Mounjaro and Zepbound, found seven factors that were significantly linked with ≥15% weight loss when taking their blockbuster medications.

According to this Medscape overview,

• Investigators conducted a post hoc analysis of data collected from a total of 3188 people with type 2 diabetes who had been adherent to their assigned tirzepatide regimen for 40–42 weeks in any one of four pivotal trials of the agent: SURPASS-1, SURPASS-2, SURPASS-3, and SURPASS-4.

1. Higher tirzepatide dose
2. Being female
3. Being of White or Asian race
4. Being of younger age
5. Undergoing treatment with metformin
6. Having better glycemic control (based on lower A1c and lower fasting serum glucose)
7. Having lower non-high-density lipoprotein non-HDL) cholesterol level.

Do these factors describe you?

To find a provider near you with these medications, please visit BuildMyBod.com/weight-management and if you’re a provider looking to implement a weight management program into your practice, request an account here.